Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4.

Jen A, Parkyn CJ, Mootoosamy RC, Ford MJ, Warley A, Liu Q, Bu G, Baskakov IV, Moestrup S, McGuinness L, Emptage N, Morris RJ.

J Cell Sci. 2010 Jan 15;123(Pt 2):246-55. doi: 10.1242/jcs.058099.

3.

Autocatalytic conversion of recombinant prion proteins displays a species barrier.

Baskakov IV.

J Biol Chem. 2004 Feb 27;279(9):7671-7. Epub 2003 Dec 10.

5.

Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane.

Goold R, McKinnon C, Rabbanian S, Collinge J, Schiavo G, Tabrizi SJ.

J Cell Sci. 2013 Aug 15;126(Pt 16):3552-62. doi: 10.1242/jcs.120477. Epub 2013 Jun 26.

6.

Prions disturb post-Golgi trafficking of membrane proteins.

Uchiyama K, Muramatsu N, Yano M, Usui T, Miyata H, Sakaguchi S.

Nat Commun. 2013;4:1846. doi: 10.1038/ncomms2873.

PMID:
23673631
7.

LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein.

Parkyn CJ, Vermeulen EG, Mootoosamy RC, Sunyach C, Jacobsen C, Oxvig C, Moestrup S, Liu Q, Bu G, Jen A, Morris RJ.

J Cell Sci. 2008 Mar 15;121(Pt 6):773-83. doi: 10.1242/jcs.021816. Epub 2008 Feb 19.

8.
9.

Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.

Meier P, Genoud N, Prinz M, Maissen M, Rülicke T, Zurbriggen A, Raeber AJ, Aguzzi A.

Cell. 2003 Apr 4;113(1):49-60.

10.

Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.

Taylor DR, Whitehouse IJ, Hooper NM.

PLoS Pathog. 2009 Nov;5(11):e1000666. doi: 10.1371/journal.ppat.1000666. Epub 2009 Nov 20.

11.

Mechanism of the metal-mediated endocytosis of the prion protein.

Hooper NM, Taylor DR, Watt NT.

Biochem Soc Trans. 2008 Dec;36(Pt 6):1272-6. doi: 10.1042/BST0361272. Review.

PMID:
19021539
12.

Protease-resistant prions selectively decrease Shadoo protein.

Watts JC, Stöhr J, Bhardwaj S, Wille H, Oehler A, Dearmond SJ, Giles K, Prusiner SB.

PLoS Pathog. 2011 Nov;7(11):e1002382. doi: 10.1371/journal.ppat.1002382. Epub 2011 Nov 17.

13.

The role of lipid rafts in prion protein biology.

Lewis V, Hooper NM.

Front Biosci (Landmark Ed). 2011 Jan 1;16:151-68. Review.

PMID:
21196164
14.

Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.

Hara H, Okemoto-Nakamura Y, Shinkai-Ouchi F, Hanada K, Yamakawa Y, Hagiwara K.

J Virol. 2012 May;86(10):5626-36. doi: 10.1128/JVI.06606-11. Epub 2012 Mar 7.

15.

Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.

Phuan PW, Zorn JA, Safar J, Giles K, Prusiner SB, Cohen FE, May BC.

J Gen Virol. 2007 Apr;88(Pt 4):1392-401.

PMID:
17374787
16.

Prion protein functions and dysfunction in prion diseases.

Sakudo A, Ikuta K.

Curr Med Chem. 2009;16(3):380-9. Review.

PMID:
19149584
17.

The role of rafts in the fibrillization and aggregation of prions.

Pinheiro TJ.

Chem Phys Lipids. 2006 Jun;141(1-2):66-71. Epub 2006 Mar 27. Review.

PMID:
16647049
18.

Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.

Kiachopoulos S, Heske J, Tatzelt J, Winklhofer KF.

Traffic. 2004 Jun;5(6):426-36.

19.

[Mechanisms of prion transmission].

Sakaguchi S.

Nihon Rinsho. 2007 Aug;65(8):1391-5. Review. Japanese.

PMID:
17695274
20.

The prion protein and lipid rafts.

Taylor DR, Hooper NM.

Mol Membr Biol. 2006 Jan-Feb;23(1):89-99. Review.

PMID:
16611584
Items per page

Supplemental Content

Write to the Help Desk